Advertisment
|
|
news roundup
The acquisition of Biomedical Systems, a well-recognized provider of reliable imaging, and cardiac safety and respiratory data collection solutions, coupled with ERT's recent addition of imaging technology invented by the Cleveland Clinic, enables ERT to further strengthens its capabilities in this area.
| advertisment
ERT Video Series
Check out the ERT video series, filmed on the show floor at DIA 2017, for interviews on Innovating Clinical Trial Management, eCOA in Clinical Research: Trends and Advances, and Optimizing Clinical Trial Imaging through Advanced Technology.
 Click here to watch all 10 short videos |
Tufts CSSD study finds cardiovascular drug approval rates trailed other drug approvals, while the mean clinical development time for cardiovascular drug approvals lengthened nearly two years from 1999-04 to 2005-10, and increased another 7% from 2005-10 to 2011-16.
Who's moved to another company and which companies are announcing changes or awards? Find out in the updated Business and People News for September.
Our latest eBook focuses on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways.
|
|
|
advertisment
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisment
Proactive Planning, a Transformational Revolution to Improving Clinical Trial Quality?
Live Webcast: Tuesday, September 26, 2017 at 1:00pm EDT
 Register now |
|
Advertisment
|
|
Articles
This article discusses the Risk-Based Quality Management theory with the application of professional RBM technology in practice, during a Project Management (PM) for the Life Science Professional course at Rutgers. The main goal for students was to create a retrospective quality risk management plan for previously failed industry studies.
| advertisment
Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
Live Webcast: Tuesday, September 19 at 2:00pm BST and Thursday, September 28 at 10am EDT
 Register now |
In response to the FDA's rapid approvals in the oncology space, sponsors need to quickly generate enough evidence to satisfy FDA requirements and innovative protocol designs are becoming more prominent in this regard.
|
|
|
Blog Posts
Austin Speier, VP of Emerging Technologies at Precision Medicine, elaborates on mHealth regulatory pathways and FDA's Digital Health Unit in this interview.
| advertisment
Accelerate NASH Development: Next-generation Approaches to Overcome Recruitment and Study Execution Challenges
On Demand
 Learn more |
Jeff Lee, CEO, mProve Health, recently moderated a panel and shares their insights on mobile engagement apps (i.e. reminders, education, etc.); BYOD ePRO; eConsent; wearables/sensors; ResearchKit; digital biomarkers; or virtual study solutions use in clinical trials.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
